Research Article
Kidney-Related Outcome in Cardiorenal Syndrome Type 3
Table 3
Distribution of predefined variables in patients with versus without the need for dialysis therapy.
| | Variable | No dialysis | Dialysis | value |
| | Gender (females in %) | 46.8 | 33.3 | 0.3 | | Age (mean years+/−SD) | 80.1+/−1.1 | 77.6+/−3 | 0.73 | | In-hospital stay (means days+/−SD) | 19.5+/−1.9 | 27.6+/−4.2 | 0.012 | | AKIN stage (1/2/3 in %) | 23.4/45.5/31.2 | 5.6/16.7/77.8 | 0.001 | | Initial serum creatinine (micro-Mol/L+/−SD) | 196.6+/−12.8 | 378.2+/−58.8 | <0.001 | | Peak serum creatinine (micro-Mol/L+/−SD) | 317.6+/−12.9 | 474.6+/−56.5 | 0.003 | | Serum creatinine before discharge (micro-Mol/L+/−SD) | 204.3+/−13.6 | 281.1+/−47.8 | 0.158 | | Initial serum sodium (mMol/L+/−SD) | 137.3+/−0.7 | 138.8+/−1.5 | 0.49 | | Minimal serum sodium (mMol/L+/−SD) | 134.9+/−0.7 | 136+/−0.8 | 0.58 | | Peak serum sodium (mMol/L+/−SD) | 143.8+/−0.6 | 145.4+/−0.7 | 0.061 | | Initial serum potassium (mMol/L+/−SD) | 4.8+/−0.1 | 5.3+/−0.2 | 0.04 | | Minimal serum potassium (mMol/L+/−SD) | 3.7+/−0.08 | 3.7+/−0.09 | 0.72 | | Peak serum potassium (mMol/L+/−SD) | 5.1+/−0.09 | 5.6+/−0.2 | 0.06 | | Initial NT-proBNP (pg/mL) | 8,953+/−1,304 | 19,322+/−4,310 | 0.02 | | Peak NT-proBNP (pg/mL) | 10,530+/−1,295 | 19,370+/−3,348 | 0.018 | | Initial CRP (mg/L+/−SD) | 54.1+/−7.1 | 39.7+/−19.1 | 0.034 | | Peak CRP (mg/L+/−SD) | 135.6+/−11.7 | 127.9+/−27.9 | 0.5 | | Vasopressors (%) | 9.1 | 5.6 | 0.62 | | Invasive ventilation (%) | 10.4 | 22.2 | 0.17 | | Arterial hypertension (%) | 89.6 | 100 | 0.15 | | Diabetes (%) | 55.8 | 61.1 | 0.68 | | Obesity (%) | 51.3 | 72.2 | 0.1 | | Preexisting CHF (%) | 27.3 | 27.8 | 0.96 | | Preexisting CAD (%) | 35.1 | 66.7 | 0.014 | | COPD (%) | 22.1 | 5.6 | 0.1 | | Hyperuricemia (%) | 22.1 | 33.3 | 0.31 | | History of cancer (%) | 29.9 | 16.7 | 0.25 |
|
|
